CIK 0001509745 · Non-accelerated filer<br>Smaller reporting company
CYPHERPUNK TECHNOLOGIES INC.
Sign in to watch- Ticker
- CYPH
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 274412575
- Phone
- 617 252 4343
- Business address
- 47 THORNDIKE STREET, SUITE B1-1, CAMBRIDGE, MA, 02142
- Former names
- LEAP THERAPEUTICS, INC., Dekkun Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $888,900
- in 3 filings
Net −$888,900. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-11-13 | ONSI DOUGLAS E CEO,CFO,Pres.,GC,Treas.&Sec. | Option exercise | +2,136 | $2.82 | $6K | 678,456 |
| 2024-11-13 | ONSI DOUGLAS E CEO,CFO,Pres.,GC,Treas.&Sec. | Option exercise · Warrant (Right to Buy) | −2,136 | 0 | ||
| 2024-11-13 | LAWLOR AUGUSTINE Chief Operating Officer | Option exercise | +2,136 | $2.82 | $6K | 678,456 |
| 2024-11-13 | LAWLOR AUGUSTINE Chief Operating Officer | Option exercise · Warrant (Right to Buy) | −2,136 | 0 | ||
| 2024-11-13 | Mirabelli Christopher Chairman of the Board | Option exercise | +2,136 | $2.82 | $6K | 678,456 |
| 2024-11-13 | Mirabelli Christopher Chairman of the Board | Option exercise · Warrant (Right to Buy) | −2,136 | 0 | ||
| 2024-10-02 | Granfield Christine VP, Head of Reg Affairs/Qual | Grant or award · Employee Stock Option (Right to Buy) | +85,000 | 85,000 | ||
| 2024-10-02 | Sirard Cynthia Chief Medical Officer | Grant or award · Employee Stock Option (Right to Buy) | +85,000 | 85,000 | ||
| 2024-10-02 | Schilsky Richard Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2024-10-02 | Richard Christian M Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2024-10-02 | Martin Patricia A. Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2024-10-02 | ONSI DOUGLAS E CEO,CFO,Pres.,GC,Treas.,&Sec. | Grant or award · Employee Stock Option (Right to Buy) | +170,000 | 170,000 | ||
| 2024-10-02 | LOSCALZO JOSEPH Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2024-10-02 | LI WILLIAM Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2024-10-02 | O'Mahony John Mark Chief Manufacturing Officer | Grant or award · Employee Stock Option (Right to Buy) | +85,000 | 85,000 | ||
| 2024-10-02 | LAWLOR AUGUSTINE Chief Operating Officer | Grant or award · Employee Stock Option (Right to Buy) | +85,000 | 85,000 | ||
| 2024-10-02 | Dietz Thomas John Director | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2024-10-02 | CAVANAUGH JAMES H Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2024-10-02 | Mirabelli Christopher Director | Grant or award · Stock Option (Right to Buy) | +85,000 | 85,000 | ||
| 2024-10-02 | Baum Jason Chief Scientific Officer | Grant or award · Employee Stock Option (Right to Buy) | +85,000 | 85,000 |
Page 7 of 18 · 348 trades